文献速递湿疹皮炎与荨麻疹药疹与重症皮肤不良反应

葡萄糖苷斑贴试验:北美接触性皮炎协作组2009-2018年经验

Patch testing with glucosides: The North American Contact Dermatitis Group experience, 2009-2018.
PubMed 文献 · J Am Acad Dermatol · 2022-05-10

该研究回顾性分析北美接触性皮炎协作组2009-2018年数据,24,097例患者中470例(2.0%)对癸基葡萄糖苷和/或月桂基葡萄糖苷斑贴试验阳性,阳性反应多具当前相关性且主要来源于个人护理产品,交叉反应率超过40%。

要点

  • 葡萄糖苷斑贴试验阳性率为2.0%(470/24,097)。
  • 阳性患者职业性皮肤病、花粉症、特应性皮炎和哮喘的比值比均较高。
  • 交叉反应率超过40%,癸基与月桂基葡萄糖苷间存在交叉反应。

核心结论

  • 葡萄糖苷斑贴试验阳性率为2.0%,反应常具临床相关性并与个人护理产品相关,交叉反应率超过40%。

研究设计与样本

  • 回顾性分析北美接触性皮炎协作组2009-2018年斑贴试验数据,癸基葡萄糖苷(5%凡士林)2009-2018年测试,月桂基葡萄糖苷(3%凡士林)2017-2018年测试。

主要发现

  • 24,097例接受癸基和/或月桂基葡萄糖苷斑贴试验的患者中,470例(2.0%)出现阳性反应。
  • 与葡萄糖苷阴性患者相比,阳性患者职业性皮肤病发生率13.4% vs 10.1%(P = .0207),花粉症史38.5% vs 31.6%(P = .0014),特应性皮炎39.0% vs 28.6%(P < .0001),哮喘21.8% vs 16.5%(P = .0023)。
  • 大多数葡萄糖苷反应(83.9%)具有当前相关性。
  • 最常见来源为个人护理产品(63.0%),尤其是毛发产品(16.5%)和皮肤清洁剂(15.2%)。
  • 在4,933例同时测试癸基和月桂基葡萄糖苷的患者中,134例(2.7%)对其中1种或2种均阳性;癸基阳性患者中43.4%(43/99)也对月桂基葡萄糖苷阳性,月桂基葡萄糖苷阳性患者中55.1%(43/78)也对癸基葡萄糖苷阳性。

局限性

  • 队列主要反映转诊人群。
  • 未捕获斑贴试验后的随访情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alkyl glucosides are nonionic surfactants that are increasingly used in personal care products. OBJECTIVE: To characterize positive patch test reactions to decyl glucoside (5% petrolatum, tested 2009-2018) and lauryl glucoside (3% petrolatum, tested 2017-2018). METHODS: Retrospective analysis of patients tested by the North American Contact Dermatitis Group. RESULTS: Of 24,097 patients patch tested to decyl and/or lauryl glucoside, 470 (2.0%) had positive reactions. Compared with glucoside-negative patients, glucoside-positive patients had higher odds of occupational skin disease (13.4% vs 10.1%; P = .0207), history of hay fever (38.5% vs 31.6%; P = .0014), atopic dermatitis (39.0% vs 28.6%; P < .0001), and/or asthma (21.8% vs 16.5%; P = .0023). Most glucoside reactions (83.9%) were currently relevant. The most common source was personal care products (63.0%), especially hair products (16.5%) and skin cleansers (15.2%). Of 4933 patients tested to decyl and lauryl glucoside, 134 (2.7%) were positive to 1 or both; 43.4% (43 of 99) of decyl-positive patients were also positive to lauryl glucoside and 55.1% (43/78) of lauryl glucoside patients were also positive to decyl glucoside. LIMITATIONS: The cohort predominantly reflects a referral population, and follow-up after testing was not captured. CONCLUSION: Glucoside positivity occurred in 2.0% of the tested patients. Reactions were often clinically relevant and linked to personal care products. Cross-reactivity was >40%.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Warshaw EM, Xiong M, Atwater AR, et al. Patch testing with glucosides: The North American Contact Dermatitis Group experience, 2009-2018. J Am Acad Dermatol. 2022. PMID: 35551968. doi:10.1016/j.jaad.2022.04.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。